Thomas S. van Solinge

CRISPR-Cas knockout of miR21 reduces glioma growth

Lisa Nieland, Thomas S. van Solinge, Pike-See Cheah et al. · Molecular Therapy — Oncolytics · 2022 · 47 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +17

The interference of genetic associations in establishing the prognostic value of the immunophenotype in acute myeloid leukemia

Thomas S. van Solinge, Wendelien Zeijlemaker, Gert J. Ossenkoppele et al. · Cytometry Part B Clinical Cytometry · 2017 · 19 citations · Full text

Life Sciences, Hematology, Oncology +16

Extracellular communication between brain cells through functional transfer of Cre mRNA mediated by extracellular vesicles

David Rufino‐Ramos, Kevin Leandro, Pedro R.L. Perdigão et al. · Molecular Therapy · 2023 · 19 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +13

Orally Administered 5-aminolevulinic Acid for Isolation and Characterization of Circulating Tumor-Derived Extracellular Vesicles in Glioblastoma Patients

Sybren L. N. Maas, Thomas S. van Solinge, Rosalie Schnoor et al. · Cancers · 2020 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17

Versatile Role of Rab27a in Glioma: Effects on Release of Extracellular Vesicles, Cell Viability, and Tumor Progression

Thomas S. van Solinge, Erik R. Abels, Lieke L. van de Haar et al. · Frontiers in Molecular Biosciences · 2020 · 12 citations · Full text

Medicine, Molecular Biology, Oncology +15